Ms. Brown will start in the position by early February 2013 and will also be named as executive director of the board.
She formerly served as interim chief financial officer for AstraZeneca, where she worked in many positions for 25 years.
More Articles on Devices:
MedShape Introduces DynaNail for Ankle Arthrodesis
Pinnacle Spine Group Receive Graft Delivery System Patent
Orthopedic & Spine Industry Company to Know: PDP Holdings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
